Clinical Trial Update: Post Marketing Surveillance Study of Cuprimine

View source ↗

Summary

This clinical trial update covers a post-marketing surveillance study of Cuprimine (penicillamine) for systemic sclerosis. The study is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Cuprimine (penicillamine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Scleroderma | Status: NO_LONGER_AVAILABLE